RSK4在现代生物医学中的研究进展
Research Progress of Ribosomal S6 Kinase 4 (RSK4) in Modern Biomedicine
DOI: 10.12677/md.2025.153041, PDF,   
作者: 何兆兴：空军军医大学基础医学院学员队一大队，陕西 西安；付思颖：空军军医大学基础医学院学员队六大队，陕西 西安；尹志勇*：空军军医大学第一附属医院心内科，陕西 西安
关键词: RSK4；信号通路；恶性肿瘤；炎症性肠病；神经退行性疾病；RSK4； Signaling Pathway； Malignant Tumor； Inflammatory Bowel Disease； Neurodegenerative Disease
摘要: RSK4作为一种核糖体S6激酶，可以通过整合多种信号通路调控下游蛋白，影响细胞增殖、分化、凋亡等生物学过程。近年来研究发现，RSK4在不同组织及疾病状态下的表达与作用存在显著差异。如在肿瘤疾病中，RSK4的作用尤为复杂，在乳腺癌等肿瘤中表现为抑癌作用，而在肾透明细胞癌等肿瘤中则呈现促癌作用。在非肿瘤性疾病如炎症性肠病和神经退行性疾病中，RSK4发挥着调节炎症、调控神经环路等潜在作用。鉴于其表达特异性与作用复杂性，目前RSK4在某些方面的作用仍存在争议。本文通过综述RSK4不同生物学作用以及相关的研究进展，旨在揭示该分子在疾病发生发展中的作用机制，为未来临床治疗工作提供理论依据。
Abstract: Ribosomal S6 kinase 4 (RSK4), a member of the ribosomal S6 kinase family, integrates multiple signaling pathways to regulate downstream proteins, thereby influencing cellular processes such as proliferation, differentiation, and apoptosis. Recent studies have shown that RSK4 expression and function vary significantly across different tissues and disease states. In cancer, RSK4 exhibits a complex role: it acts as a tumor suppressor in breast cancer, yet displays oncogenic properties in renal clear cell carcinoma. Beyond oncology, RSK4 plays potential roles in regulating inflammation in inflammatory bowel disease and modulating neural circuits in neurodegenerative diseases. Despite these findings, RSK4’s actions remain controversial due to its expression specificity and complexity. This review summarizes RSK4’s diverse biological functions and research progress, aiming to elucidate its mechanisms in disease pathogenesis and provide a theoretical basis for future clinical treatments.
文章引用：何兆兴, 付思颖, 尹志勇. RSK4在现代生物医学中的研究进展[J]. 医学诊断, 2025, 15(3): 307-313. https://doi.org/10.12677/md.2025.153041

参考文献

[1] Pang, F., Zhang, L., Li, M., Yi, X., Wang, Y., Yang, P., et al. (2023) Ribosomal S6 Protein Kinase 4 Promotes Resistance to EZH2 Inhibitors in Glioblastoma. Cancer Gene Therapy, 30, 1636-1648. [Google Scholar] [CrossRef] [PubMed]
[2] Nezamuldeen, L. and Jafri, M.S. (2024) Boolean Modeling of Biological Network Applied to Protein-Protein Interaction Network of Autism Patients. Biology, 13, Article 606. [Google Scholar] [CrossRef] [PubMed]
[3] Arechavaleta-Velasco, F., Dominguez-Lopez, P., Acosta-Jimenez, E. and Diaz-Cueto, L. (2023) Ribosomal S6 Kinase 4 (RSK4) Tumor Suppressor Gene Promoter Methylation Status in Ovarian Cancer. Molecular Biology Reports, 50, 6863-6870. [Google Scholar] [CrossRef] [PubMed]
[4] Koutsougianni, F., Alexopoulou, D., Uvez, A., Lamprianidou, A., Sereti, E., Tsimplouli, C., et al. (2023) P90 Ribosomal S6 Kinases: A Bona Fide Target for Novel Targeted Anticancer Therapies? Biochemical Pharmacology, 210, Article ID: 115488. [Google Scholar] [CrossRef] [PubMed]
[5] 刘艳红, 张哲, 王哲, 等. 食管鳞状细胞癌组织中RSK4、p63的表达变化及意义[J]. 山东医药, 2023, 63(10): 16-20.
[6] He, S., Lu, M., Zhang, L. and Wang, Z. (2024) RSK4 Promotes the Macrophage Recruitment and M2 Polarization in Esophageal Squamous Cell Carcinoma. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1870, Article ID: 166996. [Google Scholar] [CrossRef] [PubMed]
[7] Nagumo, Y., Villareal, M.O., Isoda, H. and Usui, T. (2023) RSK4 Confers Paclitaxel Resistance to Ovarian Cancer Cells, Which Is Resensitized by Its Inhibitor BI-D1870. Biochemical and Biophysical Research Communications, 679, 23-30. [Google Scholar] [CrossRef] [PubMed]
[8] 马静, 彭阳, 许军鹏, 等. RSK4小分子抑制剂在肾透明细胞癌中的作用研究[J]. 空军军医大学学报, 2024, 45(7): 800-804.
[9] 马静. RSK4促肾透明细胞癌恶性进展的分子机制及干预策略研究[D]: [博士学位论文]. 西安: 中国人民解放军空军军医大学, 2024.
[10] 杨江林, 许远红, 廖德仲. 核糖体S6蛋白激酶4基因在多种肿瘤中的表达及其生物信息学分析[J]. 实用医学杂志, 2024, 40(13): 1778-1784.
[11] Chen, L., Xu, T., Jia, Q., Wang, X., Li, M. and Liang, G. (2020) RSK4: A New Prognostic Factor in Glioma. Pathology—Research and Practice, 216, Article ID: 153020. [Google Scholar] [CrossRef] [PubMed]
[12] Chen, S., Seckl, M.J., Lorentzen, M.P.G. and Pardo, O.E. (2022) Differential Expression of RSK4 Transcript Isoforms in Cancer and Its Clinical Relevance. International Journal of Molecular Sciences, 23, Article 14569. [Google Scholar] [CrossRef] [PubMed]
[13] 张旗, 杨华伟. RSK4、ACTN4和Ki-67在乳腺癌中的表达及其临床意义[J]. 广西医科大学学报, 2022, 39(10): 1537-1541.
[14] 赵燕芸. 甲状腺乳头状癌中RSK4-PODXL通路异常的机制研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2022.
[15] Lou, R. (2024) Expression of RSK4 Protein in Non-Small Cell Lung Cancer Tissues, Adjacent Tissues and Its Correlation with Clinicopathological Features. American Journal of Translational Research, 16, 3273-3279. [Google Scholar] [CrossRef] [PubMed]
[16] 陈娜. RSK4在口腔鳞癌组织中的表达及可变剪接发生与临床意义的初步研究[D]: [硕士学位论文]. 贵阳: 贵州医科大学, 2024.
[17] 李凌霏. RSK4在溃疡性结肠炎中的作用及机制研究[D]: [硕士学位论文]. 西安: 中国人民解放军空军军医大学, 2024.
[18] Lin, Y., Xiong, W., Xiao, S., Li, F., Lu, Z., Yan, J., et al. (2020) Pharmacoproteomics Reveals the Mechanism of Chinese Dragon’s Blood in Regulating the RSK/TSC2/mTOR/Ribosome Pathway in Alleviation of DSS-Induced Acute Ulcerative Colitis. Journal of Ethnopharmacology, 263, Article ID: 113221. [Google Scholar] [CrossRef] [PubMed]
[19] Zeniou, M. (2002) Expression Analysis of RSK Gene Family Members: The RSK2 Gene, Mutated in Coffin-Lowry Syndrome, Is Prominently Expressed in Brain Structures Essential for Cognitive Function and Learning. Human Molecular Genetics, 11, 2929-2940. [Google Scholar] [CrossRef] [PubMed]
[20] Xifró, X., Anglada-Huguet, M., Rué, L., Saavedra, A., Pérez-Navarro, E. and Alberch, J. (2011) Increased 90-Kda Ribosomal S6 Kinase (RSK) Activity Is Protective against Mutant Huntingtin Toxicity. Molecular Neurodegeneration, 6, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
[21] 康馨谣, 许梅花, 董海静. 阿尔茨海默病发病机制的研究进展[J]. 中国老年学杂志, 2024, 44(22): 5625-5628.
[22] 杨李厂. 阿尔兹海默病的发病机制、早期干预和治疗研究进展[J]. 生物医学工程学进展, 2024, 45(1): 14-20.
[23] 张厚文, 朱虹, 李春荣, 等. 帕金森病伴周围神经病变的机制[J]. 中风与神经疾病杂志, 2025, 42(2): 133-136.
[24] Zeng, R., Wang, J., Jiang, R., Yang, J., Zheng, C., Wu, H., Zhuo, Z., Yang, Q., Li, J., Leung, F.W., Sha, W. and Chen, H. (2023) Investigating Causality and Shared Genetic Architecture between Neurodegenerative Disorders and Inflammatory Bowel Disease. Aging and Disease, 14, 1349-1359.
[25] Kim, J.S., Chen, M., Wang, H.E., Lu, C., Wang, Y. and Zhang, B. (2023) Inflammatory Bowel Disease and Neurodegenerative Diseases. Gut and Liver, 17, 495-504. [Google Scholar] [CrossRef] [PubMed]